Subscribe to the OSS Weekly Newsletter!

Register for the 2025 Trottier Symposium!

Don’t Play Yo-Yo with Your Weight: The ‘Post-Ozempic’ Rebound

1 Aug 2025

Body weight is determined by a complex regulatory system that is necessary to ensure survival of the species – too little food reduces body weight but, extreme caloric restriction also decreases...

A Bite into the Science of Venoms

22 Nov 2024

You are likely aware of the large number of drugs that have been developed from chemicals found in plants, including aspirin from willow bark, atropine from deadly nightshade, and both morphine and...

Leptin-A Hormone To Regulate Appetite?

8 Mar 2024

The implementation of glucagon-like peptide-1 (GLP-1)-based drugs for the treatment of obesity has been an incredible advance in the field, enabling up to 25% decreases in body weight in many...

What is next in the evolution of GLP-1-based therapies for diabetes and obesity?

15 Dec 2023

The first glucagon-like peptide-1 (GLP-1)-based therapeutic was approved by Health Canada in 2011 for the treatment of hyperglycemia in patients with Type 2 diabetes. Little was it suspected at...

Back to top